Inter-scan variability of coronary artery calcium scoring assessed on 64-multidetector computed tomography vs. dual-source computed tomography: a head-to-head comparison by Ghadri, Jelena R. et al.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
CLINICAL
Inter-scan variability of coronary artery calcium
scoring assessed on 64-multidetector computed
tomography vs. dual-source computed
tomography: a head-to-head comparison
Jelena R. Ghadri1†, Robert Goetti1†, Michael Fiechter1,2, Aju P. Pazhenkottil1,
Silke M. Ku¨est1, Rene N. Nkoulou1, Christina Windler1, Ronny R. Buechel1,
Bernhard A. Herzog1, Oliver Gaemperli1, Christian Templin1,
and Philipp A. Kaufmann1,2*
1Department of Radiology, Cardiac Imaging, University Hospital Zurich, Ramistrasse 100, NUK C 32, CH-8091 Zurich, Switzerland; and 2Zurich Centre for Integrative Human
Physiology (ZIHP), University of Zurich, Zurich, Switzerland
Received 21 March 2011; revised 22 April 2011; accepted 26 April 2011; online publish-ahead-of-print 5 May 2011
This paper was guest edited by Dr Jeroen Bax, Leiden University Medical Center, Leiden, The Netherlands
Aims Coronary artery calcium (CAC) scoring has emerged as a tool for risk stratification and potentially for monitoring
response to risk factor modification. Therefore, repeat measurements should provide robust results and low
inter-scanner variability for allowing meaningful comparison. The purpose of this study was to investigate inter-
scanner variability of CAC for Agatston, volume, and mass scores by head-to-head comparison using two different
cardiac computed tomography scanners: 64-detector multislice CT (MSCT) and 64-slice dual-source CT (DSCT).
Methods
and results
Thirty patients underwent CAC measurements on both 64-MSCT (GE LightSpeed XT scanner: 120 kV, 70 mAs,
2.5 mm slices) and 64-DSCT (Siemens Somatom Definition: 120 kV, 80 mAs, 3 mm slices) within ,100 days
(0–97). Retrospective intra-scan comparison revealed an excellent correlation. The excellent intra-scan (inter-obser-
ver) agreement was documented by narrow limits of agreement and a correlation coefficient of variation (COV) of
r ≥ 0.99 (P, 0.001) for all CAC scores with a low COV for both scanners (64-MSCT/64-DSCT), i.e. Agatston (2.0/
2.1%), mass (3.0/2.0%), and volume (4.7/3.9%). Inter-scanner comparison revealed larger Bland–Altman (BA) limits of
agreement, despite high correlation (r ≥ 0.97) for all scores, with COV at 15.1, 21.6, and 44.9% for Agatston, mass,
and volume scores. The largest BA limits were observed for volume scores (21552.8 to 574.2), which was massively
improved (2241.0 to 300.4, COV 11.5%) after reanalysing the 64-DSCT scans (Siemens) with GE software/work-
station (while Siemens software/workstation does not allow cross-vendor analysis). Phantom measurements con-
firmed overestimation of volume scores by ‘syngo Ca-Scoring’ (Siemens) software which should therefore be
reviewed (vendor has been notified).
Conclusion Intra- and inter-scan agreement of CAC measurement in a given data set is excellent. Inter-scanner variability is
reasonable, particularly for Agatston units in the clinically most relevant range ,1000. The use of different software
solutions has a greater influence particularly on volume scores than the use of different scanner types.
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Introduction
The incremental prognostic value of coronary artery calcium
(CAC) scoring beyond conventional cardiovascular risk factors in
different patient populations has been reported in a large
number of studies.1,2 As a consequence, CAC has become increas-
ingly important as a tool to detect atherosclerosis and guide the
use of measures in prevention of future cardiac events particularly
for relatively young and asymptomatic patients.3,4 Due to its non-
invasiveness, the use of CAC as a tool for monitoring response to
risk factor modification such as lipid lowering has been proposed
more than a decade ago.5 The rapid technical advances in multislice
computed tomography (MDCT) over the last years have led to a
switch from the electron beam CT (EBCT) on which the CAC
was originally introduced by Agatston et al.3 to CAC assessment
by MDCT. Particularly, the early CT scanner generations have
been extensively validated against EBCT.1,6 An increasing number
of patients is undergoing CAC scoring and potentially repeat scan-
ning for treatment monitoring7–10 in different centres with a wide
variety of CT scanners from different vendors despite the fact that
evidence of supporting clinical monitoring by CAC scoring is
lacking.11 In order to allow meaningful comparison, multi-
institutional and multi-manufacturer international standards for
quantification of CAC have been published by the Physics Task
Groups of the International Consortium on Standardization in
Cardiac CT.12 As a majority of centres performing cardiac CT
are now using 64-slice CT scanners, the knowledge of inter-scan
variability of CAC obtained on this scanner generation from differ-
ent vendors is crucial, but so far lacking. In particular, for compari-
son of data from 64-slice CT vs. 64-slice dual-source CT (DSCT)
only phantom data exist.13 Thus, the purpose of the present study
was to evaluate the head-to-head inter-scanner variability of CAC
values obtained on a 64-slice MDCT scanner vs. those obtained on
a 64-slice DSCT scanner from a different vendor.
Methods
Study population
Thirty consecutive patients who underwent CAC measurements on
both different CT scanners within an interval of 100 days were
included in this study. The unenhanced CT scan for CAC scoring
was obtained once from the attenuation correction scan at the
occasion of a myocardial perfusion scintigraphy, which the other
CAC scan was obtained as routine component of a CT coronary
angiography. Thus, both CAC scans were obtained from clinically indi-
cated routine examinations. Patients were retrospectively included in
the study if they had signed informed consent authorizing their
records to be included in our cardiac imaging research registry. Exclu-
sion criteria were arrhythmia, prior coronary artery bypass surgery or
the presence of mechanical prosthetic valves, intracoronary artery
stents, pacemakers, and implantable cardioverter defibrillators.
Before the study, a detailed interview was conducted to collect data
on symptoms, previous cardiac events, and cardiovascular risk
factors as summarized in Table 1.
Computed tomography data acquisition
Coronary artery calcium scanning was performed by non-contrast
cardiac CT using a 64-slice MDCT scanner (LightSpeed VCT XT,
GE Healthcare, Milwaukee, USA) and a 64-slice DSCT scanner
(Somatom Definition, Siemens Healthcare, Forchheim, Germany). All
scans were performed in cranio-caudal direction during inspiratory
breathold with prospective electrocardiogram (ECG)-triggering as pre-
viously reported.14 Electrocardiogram triggering was set at 75% of the
RR interval without padding for both scanners. The detailed acquisition
parameters according to the respective vendors’ recommendations for
each scanner are given in Table 2. The calcium scores obtained with the
two different scanners and respective scanning parameters were vali-
dated by phantom measurements. A commercially available anthropo-
morphic cardio-CT phantom, established and proposed by the Physics
Task Group of the International Consortium on Standardization in
Cardiac CT [in close collaboration with the vendors (GE Healthcare,
Philips Medical Systems, Siemens Medical Solutions and Toshiba
Medical Systems),12 consisting of a body (QMR-Thorax, QRM,
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Table 1 Baseline characteristics (n 5 30)
Male 23 (77%)
Age (years)
Mean+ SD 71+8
Range 52–84
BMI (kg/m2) 25+4
Hypertension 25 (83%)
Dyslipidaemia 15 (50%)
Diabetes mellitus 8 (27%)
Smoking 28 (93%)
Obesity (BMI. 30 kg/m2) 3 (10%)
Family history of premature CAD 4 (13%)
BMI, body mass index; CAD, coronary artery disease.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 2 Scan acquisition parameters for
quantification of coronary artery calcium
Scanner type DSCT
(Somatom
Definition)
MDCT
(Lightspeed VCT
XT)
Vendor Siemens GE
Acquisition mode Sequential Sequential
ECG-triggering Prospective Prospective
Tube voltage 120 kV 120 kV
Rotation time 0.33 s 0.35 s
Tube current-time
product
80 mAs 70 mAs
Detector collimation 2 × 32 × 0.6 mm 64 × 0.5 mm
Section thickness/
increment
3 mm/3 mm 2.5 mm/2.5 mm
Reconstruction kernel B35f Standard
DLP (mGy × cm) 65.7+33.1 73.1+28.6
Heart rate in b.p.m.
(range)
72.2+17.6
(44–110.5)
72.6+8.3
(54–89)
DSCT, dual-source computed tomography; MDCT, multislice computed
tomography; ECG, electrocardiogram; DLP, dose length product.
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Moehrendorf, Germany)—with artificial lungs and a spine insert sur-
rounded by soft tissue equivalent—and a cardiac calcification cali-
bration insert (QRM-CCI, QRM, Moehrendorf, Germany) containing
nine cylindrical calcifications of different size and hydroxyapatite
(HA) density was examined with both scanners using the same acqui-
sition parameters as for the patient study.12,15–17
Computed tomography data evaluation
All CAC datasets were analysed in random order by two blinded inde-
pendent observers, each with 3 years of experience in cardiac imaging,
using commercially available software packages of each respective
manufacturer (‘SmartScore’, GE Healthcare, Milwaukee, USA and
‘Syngo CaScore’, Siemens Healthcare, Forchheim, Germany). Coron-
ary artery calcium scores were separately obtained for each of the
main epicardial coronary arteries [left main artery (LMA), left anterior
descending artery (LAD), left circumflex artery (LCX), and right cor-
onary artery (RCA)]18 and summed to obtain total CAC. For every
patient, CAC values were calculated using three different algorithms
according to the recommendations for standardization from the
above-mentioned Consortium12 yielding the Agatston,3 volume,19
and mass scores.20 Details of these algorithms have been described
extensively elsewhere.12,21 Briefly, their respective formulas are as
follows:
Agatston score = slice increment
slice thickness
×
∑
(area× cofactor)
Mass score =
∑
(area× slice increment
× meanCTdensity) × calibration factor
Volume score =
∑
(area× slice increment)
where S includes the sum of the values in parenthesis obtained from
each individual lesion.
For the phantom study, six different cylinders of two sizes
(3 × 3 mm and 5 × 5 mm) and three different HA densities
(200 mg/cm3 HA, 400 mg/cm3 HA, and 800 mg/cm3 HA) were
scored using the same software packages as for the patient study.12
Cross-vendor analysis
All images acquired on the 64-DSCT (Siemens) were transferred to
the GE workstation/software to obtain a cross-vendor analysis of
Agatston, mass, and volume scores. Conversely, Siemens
workstation/software does not allow analysing data from GE scans.
Therefore, we could only perform cross-vendor analysis of 64-DSCT
(Siemens) data on GE software (but not vice versa).
Image quality assessment
The image quality of CAC scans regarding motion artefacts was visually
assessed for each coronary artery on a five-point scale as previously
reported22: 1, no motion artefact; 2, minor artefact (slight blurring in
less than half of the course of the vessel); 3, moderate artefact
(severe blurring or double-imaged structures in more than half of
the course of the vessel); 4, severe artefact (doubling and blurring
over the whole course of the major vessel); 5, non-diagnostic
(vessel structures not differentiable).22 The LMA was assigned to the
LAD vessel.
In addition, image noise was measured by one observer not involved
in the image quality or reproducibility assessment. It was defined as the
standard deviation of attenuation measured in a region of interest
(ROI) that was placed in the ascending aorta at the level of the coron-
ary ostia. The ROI was chosen as large as possible, excluding the vessel
wall to avoid partial volume effects.
Radiation dose estimation
Values for effective radiation dose were calculated by multiplying the
dose length product (DLP) with a conversion factor (k ¼ 0.014 mSv/
mGy × cm) as previously described23 and adopted in large trials.24
Statistical analysis
Statistical analysis was performed using SPSS software (18.0, SPSS Inc.,
Chicago, IL, USA). Quantitative variables were expressed as mean+
standard deviation (SD) or median (range) as appropriate, and categ-
orical variables as frequencies or percentages. Differences in total
calcium scores (for Agatston, mass, and volume scores) regarding
intra- and inter-observer and inter-scan comparison were analysed
by Wilcoxon signed ranks test. To assess intra-observer variability,
each reader evaluated all datasets twice after a minimum delay of 2
weeks. Inter-scan agreement was performed by comparing CAC
obtained on the two scanner types in each patient. Intra- and inter-
observer variability as well as inter-scan agreement were assessed
using Spearman’s correlation and Bland–Altman (BA) analysis with
limits of agreement as previously reported.25 Data were log(log10)
transformed to reduce skewness of the given values and used to
show regression analyses. The coefficient of variation (COV) was cal-
culated as SD/mean and expressed as a percentage for better compari-
son of the values. The standard error of the estimates was assessed to
characterize the linear fit of the data.
Image quality was correlated to the mean heart rate and differences
in image quality between 64-MDSCT and 64-DSCT were assessed
using chi-square test. Differences in image noise were tested using Wil-
coxon signed-rank test and the influence of body mass index (BMI) on
image noise was evaluated by regression analysis. All P-values were
two-sided and a P-value of ,0.05 was considered statistically
significant.
Results
Study population
Thirty patients (seven females, age 71+8 years, BMI: 25+ 4 kg/
m2) underwent successful scanning on both scanner types
(64-MDCT and 64-DSCT) within 23+27 days (range 0–97
days) and were included in the present study. The patient baseline
characteristics are listed in Table 1. The sequence of CAC scanning
was 64-MDCT first in 19 patients and 64-DSCT first in 11 patients.
None of the patients received intravenous beta-receptor antagon-
ists prior to the scan.
Phantom study
Calcium scores of the six inserts obtained with the two scanners in
the phantom were nearly identical regarding Agatston score
(64-DSCT: 695; 64-MDCT: 690) and highly accurate for the
mass scores (calibrated phantom mass: 167 mg; 64-DSCT:
167 mg; 64-MDCT: 165 mg) (Table 3). However, while volume
scores from 64-MDCT were slightly underestimated for
low-density lesions, volume scores from 64-DSCT were highly
overestimated for intermediate and high-density lesions. Thus,
the differences in volume scores could be largely attributed to
the software used for CAC scoring rather than the scanner.
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In fact, when the volume scores from 64-DSCT Siemens scanner
and Siemens software were recalculated by the GE software, the
values were substantially closer to the phantom values (Table 3),
indicating that not the Siemens scanner but rather the quantifi-
cation algorithm in the Siemens software ‘syngo CaScoring’
accounted for the inaccurate volume score measurements in inter-
mediate and high-density lesions.
Intra-scan comparison: intra- and
inter-observer variation
Intra- and inter-observer agreements of Agatston, mass, and
volume scores were excellent for both scanner types as evidenced
by strong and significant correlations with narrow limits of agree-
ment (Table 4).
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Table 4 Intra-scan comparison: intra- and inter-observer variability of coronary artery calcium for Agatston, mass, and
volume scores, (n 5 30)
Median (range) Intra-observer Inter-observer
Oberver I Observer II r Diff BA COV SEE r Diff BA COV SEE
64-MDCT (GE)
Agatston score 847 (0–5145) 850 (0–5156) 0.999* 26.8 275.8–62.2 2.2 35.9 0.997* 217.7 2101.0–65.5 2.0 41.5
Mass score 114 (0–846) 117 (0–856) 0.995* 22.7 223.3–17.8 3.6 9.35 0.989* 20.3 225.7–25.2 3.0 12.7
Volume score 341 (0–1637) 357 (0–1663) 0.991* 20.9 256.8–55.0 4.4 28.9 0.991* 29.7 276.1–56.7 4.7 33.9
64-DSCT (Siemens)
Agatston score 776 (0–4316) 777 (0–4316) 1.0* 27.5 284.8–69.8 1.3 37.7 1.0* 27.5 2102.8–87.9 2.1 45.1
Mass score 146 (0–975) 146 (0–975) 1.0* 21.9 216.2–12.5 1.7 6.7 0.999* 21.4 219.9–17.1 2.0 8.9
Volume score 618 (0–3464) 621 (0–3464) 0.998* 27.1 269.8–55.5 1.4 30.1 0.994* 23.8 2117.4–125.0 3.9 59.0
CAC, coronary artery calcium score; BA, Bland–Altman limits of agreement; Diff, difference; COV, coefficient of variation (%); SEE, standard error of the estimates.
*P, 0.01.
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Table 5 Inter-scanner head-to-head comparison: 64-multislice computed tomography vs. 64-slice dual-source
computed tomography (n5 30)
All scans analysed by dedicated software (SmartScore GE
or syngo Ca-Scoring Siemens)a
All scans analysed by SmartScore (GE)b
r Diff BA COV SEE r Diff BA COV SEE
Agatston 0.976* 2148.7 21225.9–928.5 15.1 536.5 0.987* 171.0 2640.3–983.0 10.4 364.1
Mass 0.975* 253.6 2182.0–74.8 21.6 49.1 0.984* 6.0 283.1–95.7 16.5 35.8
Volume 0.971* 2489.3 21552.8–574.2 44.9 148.9 0.990* 30.0 2241.0–300.4 11.5 133.0
CAC, coronary artery calcium score; Diff, difference; BA, Bland–Altman limits of agreement; COV, coefficient of variation (%); SEE, standard error of the estimates.
aScans were analysed by dedicated software and workstation from same vendor as for the scanner.
bData from 64-DSCT (SIEMENS scanner) analysed by GE workstation/software, while data from 64-MSCT (GE) cannot be analysed by Siemens workstation/software.
*P, 0.01.
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 3 Volume scores obtained from a phantom containing lesions (119 mm3) with different densities
Scanner Workstation Density measurement
Low Intermediate High
MDCT(GE) GE 83 114 116
MDCT(GE) Siemens n/a n/a n/a
DSCT(Siemens) Siemens 115 238 308
DSCT (Siemens) GE 82 127 99
n/a, not applicable, hydroxyapatite density is given as low for 200 mg/cm3, intermediate for 400 mg/cm3, and high for 800 mg/cm3 phantom lesions; workstation includes dedicated
software from same vendor
J.R. Ghadri et al.1868
Inter-scanner comparison
For all inter-scanner CAC measurements results are summarized
in Table 5 and illustrated in Figure 1. Inter-scanner comparison
for Agatston scores revealed an excellent correlation (r ¼ 0.976,
P, 0.01), despite relatively wide limits of agreement and a COV
of 15.1%. Mass score comparison between the two scanners also
revealed excellent correlation (r ¼ 0.975, P, 0.01) with a COV
of 21.6%. Although inter-scan correlation of volume scores was
Figure 1 Inter-scanner correlations (left panel, logarithmic scale) and Bland–Altman limits of agreement (right panel) are given for Agatston
(A), mass (B), and volume score (C). Scans were analysed by dedicated software and workstation from same vendor as for scanner on which
data were acquired. AU indicates Agatston Units.
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also excellent (r ¼ 0.971, P, 0.01), BA analysis revealed wide
limits of agreement and a substantial bias towards lower values
from 64-MDCT compared with 64-DSCT resulting in high
COV 44.9%.
Cross-vendor analysis
Interestingly, by use of GE software for Siemens scans, the
COV decreased substantially compared with original analysis
Figure 2 The reanalysis of Siemens scans by GE software/workstation eliminates the variability introduced by differences in dedicated soft-
ware/workstation. This is illustrated by narrowing of Bland–Altman limits of agreement compared with Figure 1 for Agatston (A), mass (B), and
most impressively for volume score (C). As GE data and Siemens software are not compatible, no such cross-vendor analysis is available.
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for the Agatston (10.4 vs. 15.1%), mass (16.5 vs. 21.6%) and
particularly for volume (11.5 vs. 44.9%) scores (Table 5 and
Figures 2 and 3).
Coronary artery calcium image quality
There was no significant difference in image quality between the
two scanners (Figure 4) for any of the coronary vessels and for
the overall image quality (Table 6). However, overall image
quality tended to be superior in 64-DSCT. Diagnostic image
quality was found in all 64-DSCT and 64-MDCT scans. For both
scanners, the image quality was significantly inferior in the RCA
vs. LCX (P, 0.05).
Image noise tended to be lower in 64-MDCT compared with
64-DSCT (21.0 HU+ 6.6 HU) vs. (23.4 HU+ 6.6 HU) without
reaching statistical significance (P. 0.067). Regression analysis
showed a statistically significant influence of the patient’s BMI on
image noise for both scanner types (P, 0.05).
Radiation dose
The average DLP was 73+28.6 mGy cm (effective dose: 1+
0.4 mSv) on 64-MDCT and 65.7+33.1 mGy × cm (effective
dose: 0.9+ 0.5 mSv) on 64-DSCT (n.s.).
Discussion
The present study reports an excellent intra- and inter-observer
reproducibility and a good inter-scanner agreement of coronary
CAC assessment between a 64-slice MDCT and a 64-slice DSCT
scanner from two different vendors, with decreasing agreement
at increasing calcium scores.
The Multi-Ethnic Study of Atherosclerosis (MESA) has also evalu-
ated the inter-scan variability and provided repeatability limits.6,26
These limits are important to evaluate whether an increase in
CAC score exceeds that expected from natural progression or
that of measurement error alone.27 The present study confirms an
Figure 3 In intermediate (400 mg/cm3) and high-density (800 mg/cm3) lesions 64-slice dual-source computed tomography (Siemens) sub-
stantially overestimates the volume scores, while 64-multislice computed tomography (GE) slightly underestimates volume scores in low-
density lesions (200 mg/cm3) compared with calibrated phantom which has been previously established.12
Figure 4 Axial images demonstrating calcifications in all three epicardial vessels of a 70-year-old patient with equal image quality from
non-enhanced 64-MDCT (GE) (A) and form 64-DSCT (Siemens) (B).
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excellent intra- and inter-observer reproducibility of CAC on each
scanner. For all scores including Agatston, volume, and mass
scores across a wide range of CAC values. The present data on
intra- and inter-observer reproducibility are in line with previous
findings.28
Our study is the first to report a head-to-head inter-scanner
comparison between two of the most widely used scanner
types. Only few studies have reported similar comparisons,29,30
and theses comparisons were made by using techniques which
are now outdated. For Agatston scores, we found a COV of
15.1% comparing well with the values reported in the literature
(19–37%).19,20,31–33 Inter-scanner variability for mass score was
21.6%, while it was substantially higher for the volume scores
(44.9%) despite similar intra- or inter-observer variability for this
measurement. Interestingly, when recalculating CAC from
64-DSCT scans (Siemens) using the workstation/software of the
other vendor (GE), there was a significant decrease in volume
scores, resulting in a substantial reduction of the COV to 11.5%.
Although our results suggest that accurate and reliable CAC data
can be obtained from both scanners’ values of volume scores
differ significantly from the two vendors, mainly due to differences
in the quantification algorithm although differences in slice thick-
ness may lead to differences in partial volume artefacts affecting
predominantly the volume score.
The phantom measurements revealed a slight underestimation
(230%) of volume scores in low-density lesions by GE soft-
ware/workstation. In contrast, a massive overestimation of
volume scores has been found in intermediate (+100%) and
high-density lesions (+159%) by Siemens software/workstation
(Figure 3) which should therefore be reviewed (vendor has
been notified).
From the BA plot for Agatston scores, it can be concluded
that despite a good correlation over the whole range of
values the agreement is best for values ,1000, while it
decreases in patients with extensive calcifications. This is impor-
tant because absolute precision of repeat measurements appears
most relevant in patients without excessive calcifications, in
whom risk factor modification may slow progression and there-
fore its monitoring may be appropriate. The volume score has
been suggested as a favourable alternative to the traditional
Agatston score as it allows robust assessment of the extent
to which the volume of atherosclerosis plaque may decrease,
stabilize, or increase using lipid lowering treatment.5,20
The multimanufacturer international standards for CAC measur-
ing12 may have, at least in part, contributed to the robustness of such
measurements even in cross-vendor comparison. This now allows
tracking atherosclerosis progression on different scanners from
different vendors19,20 although accuracy of the results calculated
from various types of software on different workstations may
require validation against a reference phantom. Whether the var-
iance of measurements as evidenced in the present study allows
obtaining clinically acceptable results will remain a matter of clinical
judgement in each study setting. Across the literature, progression of
CAC score is generally given as per cent change from the baseline
value because greater absolute changes are observed in patients
with higher baseline scores in whom even a large CAC increase
does not necessarily reflect a pronounced clinical deterio-
ration.21,34–38 Raggi et al.34 have suggested a change.15% for Agat-
ston score within 1 year as a clinically meaningful progression.
The inter-scanner COV for Agatston scores (15.1%) lies sub-
stantially below the typically reported values of the annual CAC
progression rates of 20–24% per year.21 Thus, while intervals
shorter than 1–2 years may be of questionable value,11,39 monitor-
ing CAC progression over time does not necessarily require the
repeat scan being performed on the same device of the same
vendor. At present, an individualized algorithm, rather than a sys-
tematic performance of serial CAC measurement seems appropri-
ate based on the existing evidence.39
Study limitations
First, we do not have data on repeat measurements on the same
scanner which would directly support the notion that rescanning
should be performed on the same scanner for obtaining optimal
agreement, although published data seem to suggest this.40
However, such analysis was beyond the scope of the present
study because it would require four scans per patient, i.e. two
scans in each subject with each scanner. Secondly, in the present
study, no systematic use of beta-blocker for heart rate regulation
and slowing was implemented. Although this may account for
some part of the inter-scan variability, the fact that each patient
served as his own control may have counterbalanced this draw-
back strengthening the validity of our data. In this context, it
should be emphasized that the design of the present study does
not allow evaluating systematic technology-related biases
towards higher accuracy of one type of scanner over the other.
This is particularly true for Agatston score which represents a
mathematical construct and therefore cannot be compared with
a physical standard of reference in contrast to mass and volume
scores.
Finally, the median Agatston score was over 750, indicating that
the patients represent a high-risk population which potentially
limits the generalizability of our results. On the other hand,
however, inclusion of many patients without coronary calcifica-
tions would have added only limited information to CAC compar-
ability. We, therefore, felt it preferable including a wide range of
CAC (0-5156 Agatston score).
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Table 6 Image quality
64-MDCT (GE) 64-DSCT (Siemens) P
Mean+ SD Mean+ SD
LMA/LAD 1.8+1.1 1.4+0.7 0.14
LCX 1.8+1.1 1.4+0.7 0.47
RCA 2.3+1.0* 1.9+0.9*I¨ 0.12
Overall 2.0+1.0 1.6+0.7 0.21
LAD, left anterior descending (including ¼ left main artery); LCX, left circumflex
artery; RCA, right coronary artery.
*P, 0.05 vs. LCX.
I¨P, 0.05 vs. LMA/LAD.
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Conclusions
Intra-scanner variability (intra- and inter-observer comparison) of
CAC scoring in a given data set is excellent. Inter-scanner variabil-
ity is reasonable, particularly for Agatston scoring in the clinically
most relevant range ,1000. The use of different software sol-
utions for CAC scoring has a greater influence on volume scores
than the use of different scanner types.
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